Upjohn

Last updated
The Upjohn Company
Industry Pharmaceutical
Founded1886 (1886)
Defunct1995;29 years ago (1995)
FateMerged with Pharmacia to form Pharmacia & Upjohn
Successor Pharmacia & Upjohn
Viatris
Headquarters Portage MI, U.S.
Logo of Upjohn Pill & Granule, later The Upjohn Company Upjohn's Friable Pills.jpg
Logo of Upjohn Pill & Granule, later The Upjohn Company

The Upjohn Company was an American pharmaceutical manufacturing firm (est. 1886) in Hastings, Michigan, by Dr. William E. Upjohn, a 1875 graduate of the University of Michigan medical school. The company was originally formed to make friable pills, specifically designed to be easily digested. [1] These pills could be "reduced to a powder under the thumb", which is how they were initially marketed.

Contents

History

Unicap, a multivitamin produced by Upjohn. Unicap Upjohn.jpg
Unicap, a multivitamin produced by Upjohn.

Upjohn developed a process for the large scale production of cortisone. The oxygen atom group must be in position 11 for this steroid to function. There are, however, no known natural starting materials with an oxo-group in position 11. The only method for preparing cortisone prior to 1952 was a lengthy synthesis, starting from cholic acid isolated from bile. In 1952, two Upjohn biochemists, Dury Peterson and Herb Murray, announced that they had invented a new method by fermenting the steroid progesterone with a common mold of the genus Rhizopus. Over the next several years, a group of chemists headed by John Hogg developed a process for preparing cortisone from the soybean sterol stigmasterol. The microbiological oxygenation invented by Peterson and Murry is a key step in this process. [2]

Subsequently, Upjohn (together with Schering) biochemically converted cortisone into the more potent steroid prednisone via bacterial fermentation. [3] [4] In chemical research, the company is known for the development of the Upjohn dihydroxylation by V. VanRheenen, R. C. Kelly, and D. Y. Cha in 1976. [5] Upjohn's best known drugs before its acquisition by Pfizer were Xanax, Halcion, Motrin, Lincocin, and Rogaine.[ citation needed ][ when? ]

In 1995, Upjohn merged with Pharmacia AB to form Pharmacia & Upjohn. [6] The company was owned by Pfizer from 2002 until 2020.

In 2015, Pfizer resurrected the Upjohn brand name for a division which manufactures and licenses drugs with patents that have expired. As of 2019, Pfizer planned to divest itself of this business in 2020. [7]

In July 2019, Pfizer announced plans to merge Upjohn with Mylan. [8] The merger was expected to close in the first half of 2020, but was delayed due to the COVID-19 pandemic. [9] The merger was completed in November 2020, and the new company was named Viatris. [10]

See also

Related Research Articles

<span class="mw-page-title-main">Corticosteroid</span> Class of steroid hormones

Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones. Two main classes of corticosteroids, glucocorticoids and mineralocorticoids, are involved in a wide range of physiological processes, including stress response, immune response, and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior.

<span class="mw-page-title-main">Pfizer</span> American multinational pharmaceutical and biotechnology corporation

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).

<span class="mw-page-title-main">Percy Lavon Julian</span> American research chemist (1899-1975)

Percy Lavon Julian was an American research chemist and a pioneer in the chemical synthesis of medicinal drugs from plants. Julian was the first person to synthesize the natural product physostigmine, and a pioneer in industrial large-scale chemical synthesis of the human hormones progesterone and testosterone from plant sterols such as stigmasterol and sitosterol. His work laid the foundation for the steroid drug industry's production of cortisone, other corticosteroids, and artificial hormones that led to birth control pills.

<span class="mw-page-title-main">Prednisone</span> Steroid medication

Prednisone is a glucocorticoid medication mostly used to suppress the immune system and decrease inflammation in conditions such as asthma, COPD, and rheumatologic diseases. It is also used to treat high blood calcium due to cancer and adrenal insufficiency along with other steroids. It is taken by mouth.

<span class="mw-page-title-main">Pharmacia & Upjohn</span> Global pharmaceutical company

Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995. Today the remainder of the company is owned by Pfizer. In 1997, Pharmacia & Upjohn sold several brands to Johnson & Johnson, including Motrin and Cortaid.

<span class="mw-page-title-main">Nasal spray</span> Spray that delivers medications locally in the nasal cavities or systemically

Nasal sprays are used to deliver medications locally in the nasal cavities or systemically. They are used locally for conditions such as nasal congestion and allergic rhinitis. In some situations, the nasal delivery route is preferred for systemic therapy because it provides an agreeable alternative to injection or pills. Substances can be assimilated extremely quickly and directly through the nose. Many pharmaceutical drugs exist as nasal sprays for systemic administration. Other applications include hormone replacement therapy, treatment of Alzheimer's disease and Parkinson's disease. Nasal sprays are seen as a more efficient way of transporting drugs with potential use in crossing the blood–brain barrier.

<span class="mw-page-title-main">Formoterol</span> Long-acting bronchiodilator

Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol has an extended duration of action compared to short-acting β2 agonists such as salbutamol (albuterol), which are effective for 4 h to 6 h. Formoterol has a relatively rapid onset of action compared to other LABAs, and is effective within 2-3 minutes. The 2022 Global Initiative for Asthma report recommends a combination formoterol/inhaled corticosteroid inhaler as both a preventer and reliever treatment for asthma in adults. In children, a short-acting β2 adrenergic agonist is still recommended.

<span class="mw-page-title-main">Pancreatic enzymes (medication)</span> Amylase, lipase, and protease mixture

Pancreatic enzymes, also known as pancreases or pancrelipase and pancreatin, are commercial mixtures of amylase, lipase, protease and lactase. They are used to treat malabsorption syndrome due to certain pancreatic problems. These pancreatic problems may be due to cystic fibrosis, surgical removal of the pancreas, long term pancreatitis, pancreatic cancer, or MODY 5, among others. The preparation is taken by mouth.

<span class="mw-page-title-main">Doxazosin</span> Group of stereoisomers

Doxazosin, sold under the brand name Cardura among others, is a medication used to treat symptoms of benign prostatic hyperplasia, hypertension, and post-traumatic stress disorder (PTSD). For high blood pressure, it is a less preferred option. It is taken by mouth.

<span class="mw-page-title-main">Latanoprost</span> Chemical compound

Latanoprost, sold under the brand name Xalatan among others, is a medication used to treat increased pressure inside the eye. This includes ocular hypertension and open-angle glaucoma. Latanaprost is applied as eye drops to the eyes. Onset of effects is usually within four hours, and they last for up to a day.

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.

<span class="mw-page-title-main">Eletriptan</span> Chemical compound

Eletriptan, sold under the brand name Relpax and used in the form of eletriptan hydrobromide, is a second-generation triptan medication intended for treatment of migraine headaches. It is used as an abortive medication, blocking a migraine attack which is already in progress. Eletriptan is marketed and manufactured by Pfizer Inc.

<span class="mw-page-title-main">Eplerenone</span> Chemical compound

Eplerenone, sold under the brand name Inspra, is an aldosterone antagonist type of potassium-sparing diuretic that is used to treat chronic heart failure and high blood pressure, particularly for people with resistant hypertension due to elevated aldosterone. It is a steroidal antimineralocorticoid of the spirolactone group and a selective aldosterone receptor antagonist (SARA).

<span class="mw-page-title-main">Nicergoline</span> Chemical compound

Nicergoline, sold under the brand name Sermion among others, is an ergot derivative used to treat senile dementia and other disorders with vascular origins. Internationally it has been used for frontotemporal dementia as well as early onset in Lewy body dementia and Parkinson's dementia. It decreases vascular resistance and increases arterial blood flow in the brain, improving the utilization of oxygen and glucose by brain cells. It has similar vasoactive properties in other areas of the body, particularly the lungs. Unlike many other ergolines, such as ergotamine, nicergoline is not associated with cardiac fibrosis.

The Marker degradation is a three-step synthetic route in steroid chemistry developed by American chemist Russell Earl Marker in 1938–1940. It is used for the production of cortisone and mammalian sex hormones from plant steroids, and established Mexico as a world center for steroid production in the years immediately after World War II. The discovery of the Marker degradation allowed the production of substantial quantities of steroid hormones for the first time, and was fundamental in the development of the contraceptive pill and corticosteroid anti-inflammatory drugs. In 1999, the American Chemical Society and the Sociedad Química de México named the route as an International Historic Chemical Landmark.

<span class="mw-page-title-main">Fred Hassan</span> American businessman

Fred Hassan, is a Pakistan-born American business executive who works for the private equity giant Warburg Pincus and previously was CEO of three global pharmaceutical companies.

<span class="mw-page-title-main">Heather Bresch</span> American business executive

Heather Bresch is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. Bresch has been a central figure in two controversies: a 2007 accusation of inflating her resume with an unearned MBA degree, and as the CEO of Mylan during the 2016 controversy over pricing of the company's EpiPen products. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list.

SUGEN (Sugen) was a drug discovery company focused on development of protein kinase inhibitors. It was founded in 1991, and shut down in 2003, after developing the pioneering kinase inhibitor drug sunitinib (Sutent).

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.

References

  1. Lohrstorfer, Martha; Larson, Catherine (2002). "William E. Upjohn: Person of the Century 1853 - 1932". Kalamazoo Public Library. Archived from the original on September 28, 2007.{{cite web}}: CS1 maint: unfit URL (link)
  2. Hogg, John A. (1992). "Steroids, the steroid community, and Upjohn in perspective: A profile of innovation". Steroids. 57 (12): 593–616. doi:10.1016/0039-128X(92)90013-Y. PMID   1481225. S2CID   21779154.
  3. "Prednisone Half Life Is A Good Medicine". PrednisoneSideEffects.org. Archived from the original on January 11, 2012.{{cite web}}: CS1 maint: unfit URL (link)
  4. "DailyMed - DELTASONE- prednisone tablet". dailymed.nlm.nih.gov.
  5. Vanrheenen, V.; Kelly, R.C.; Cha, D.Y. (1976). "An improved catalytic OsO4 oxidation of olefins to cis-1,2-glycols using tertiary amine oxides as the oxidant". Tetrahedron Letters. 17 (23): 1973–6. doi:10.1016/S0040-4039(00)78093-2.)
  6. "Upjohn Company". Resource Informagen. Archived from the original on May 7, 2006.{{cite web}}: CS1 maint: unfit URL (link)
  7. Nathan-Kazis, Josh (September 19, 2019). "Pfizer Is Spinning Off Upjohn. What's Left Will Be No Bargain, Analyst Says". Barron's . Retrieved March 30, 2020.
  8. Valinsky, Jordan (29 July 2019). "Viagra and EpiPen drugmakers form a $20-billion-a-year powerhouse". CNN. Retrieved 2020-05-07.
  9. Gough, Paul (26 March 2020). "Mylan delays merger with Upjohn due to COVID-19 pandemic". Pittsburgh Business Times.
  10. Sabatini, Patricia (16 November 2020). "Mylan completes merger with Upjohn to form Viatris". Pittsburgh Post-Gazette. Retrieved 2020-11-18.